Related Experiment Videos
Systemic chemotherapy in patients with renal failure
L Bekele1, M Vidal Vazquez, A A Adjei
1Mayo Medical School, Rochester, Minnesota, USA.
American Journal of Clinical Oncology
|July 28, 2001
Summary
Systemic chemotherapy is challenging in patients with severe renal failure. This case study shows successful treatment with paclitaxel and carboplatin for bladder cancer, offering hope for similar patients.
Area of Science:
- Oncology
- Nephrology
- Pharmacology
Background:
- Systemic chemotherapy administration is complex in patients with moderate-to-severe organ impairment.
- Limited guidelines exist for chemotherapy dose adjustments in renal failure.
- Oncologists often withhold chemotherapy for patients with severe renal dysfunction.
Observation:
- A patient with metastatic transitional cell carcinoma of the bladder and renal failure was treated.
- The patient received systemic chemotherapy with paclitaxel and carboplatin.
Findings:
- Successful administration of paclitaxel and carboplatin chemotherapy was achieved.
- The patient's metastatic transitional cell carcinoma was managed effectively despite renal failure.
Implications:
- This case suggests that paclitaxel and carboplatin can be safely administered to patients with severe renal dysfunction.
- Further data review on systemic chemotherapy in severe renal dysfunction is warranted.
- This approach may offer viable treatment options for cancer patients with co-existing renal failure.